How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million

16 Dec

Edinburgh-based biotech pioneer behind technology described as the “holy grail for emerging gene therapies” has been given a £3 million funding injection.

Concinnity Genetics - co-founded by Jessica Birt and Matthew Dale - has developed novel control mechanisms using a cutting-edge artificial intelligence (AI) platform and its synthetic biology expertise.

The Scotsman

#ScottishEnterprise#UniversityofEdinburghConcinnityGenetics#BioTechnolgy#ArtificialIntelligence#funding

Lesley Parsons

How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million

Why birth of IVF calf Hilda in Scotland is being hailed as a milestone for greener farming

Converge appoints new executive director